Saks, Nordstrom, Ma...
Health Care: Drugs
MEI Pharma Inc (MEIP: NASDAQ)
$8.48 -0.06 | -0.70%
05/21/13 - 04:00 PM ET
Company Profile
| Price and Volume | |
|---|---|
| Recent Price | 8.54 |
| 52 Week High | 13.18 |
| 52 Week Low | 1.98 |
| Avg. Daily Vol. (Mil) | 0.08 |
| Beta (3 year) | 1.56 |
| Share Related Items | |
| Mkt Cap (Mil) | 146.18 |
| Shares Out (Mil) | 17.12 |
| Float (Mil) | 7.43 |
| Dividend Information | |
| Yield % | 0.00 |
| Annual Dividend | 0.00 |
| Payout Ratio | 0.00 |
| Financial Strength | |
| Quick Ratio | 13.00 |
| Current Ratio | 13.70 |
| LT Debt/ Equity | 0.00 |
| Total Debt / Equity | 0.00 |
| Valuation Ratios | |
| Price Earnings | n.a. |
| Price/Sales | 0.00 |
| Price/Book | 6.31 |
| Price/Cash Flow | -14.60 |
| Per Share Data | |
| Earnings | -2.06 |
| Sales | 0.00 |
| Book Value | 1.35 |
| Cash Flow | -0.59 |
| Business Summary | |
|---|---|
| MEI Pharma Inc is a developing cancer therapeutics based on the central design of naturally occurring compounds called isoflavones. | |
| General Information | |
| 11975 El Camino Real
Suite 101 San Diego, CA 92130 |
|
| www.meipharma.com | |
| Industry : Drugs | |
| Sector: Health Care | |
| Employees: 10 | |
| CEO: Daniel P. Gold,PhD | |
| Short Interest | |
| Current Month (Mil) | 0.27 |
| Previous Month (Mil) | 0.26 |
| Short Interest Ratio (Days) | 3.10 |
| Management Effectiveness | |
| Return on Equity | n.a. |
| Return on Assets | -40.40 |
| Return on Investments | -43.00 |
| Profitability | |
| Gross Margin | n.a. |
| EBIT Margin | n.a. |
| Profit Margin | 0.00 |
Portfolios with MEIP
- Portfolio NameUser Type
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Moving Hig...
- ContributorStocks Under-$10 Setting Up...
- ContributorBreakout Stocks Of The Week...
- ContributorStocks Under-$10 Setting Up...
- ContributorStocks Under-$10 Moving Hig...
Latest MEIP Headlines from TheStreet
- 8 Stocks Under $10 Trending Sharply Higher 05.14.13 | 11:05 pm
- 5 Health Care Stocks Under $10 Ready to Rip Higher 04.18.13 | 09:04 pm
- 5 Stocks Under $10 Set to Soar Higher 04.11.13 | 02:04 pm
- 5 Stocks Under $10 Set to Soar 02.28.13 | 01:02 pm
- 4 Under-$10 Tech Stocks Making Large Moves 12.06.12 | 02:12 pm
Press Releases for MEIP
- MEI Pharma CEO To Present At Needham Healthcare Conference - PR Newswire 04.23.13 | 09:04 am
- MEI Pharma's Mitochondrial Inhibitor Drug Candidate ME-344 Delays Tumor Growth In Recurrent Ovarian Cancer Model - PR Newswire 04.10.13 | 04:04 pm
- MEI Pharma Announces $15.2 Million Registered Offering Of Common Stock - PR Newswire 04.05.13 | 07:04 am
- MEI Pharma To Host Annual Meeting Of Stockholders - PR Newswire 03.20.13 | 09:03 am
- MEI Pharma CEO To Present At ROTH Conference - PR Newswire 03.12.13 | 09:03 am
- MEI Pharma To Present At Cowen And Company Health Care Conference - PR Newswire 02.27.13 | 09:02 am
- MEI Pharma Adds Cancer Drug Development Veteran Tom Reynolds To Board Of Directors - PR Newswire 02.11.13 | 09:02 am
- Lifshitz Law Firm Announces Investigation Of Arrowhead Research Corp., MEI Pharma, Inc., Park City Group, Inc., And The Toro Company - PR Newswire 02.07.13 | 05:02 pm
- MEI Pharma Announces Retirement Of Chairman Bryan Williams From Board Of Directors And Appointment Of Christine White As Lead Director - PR Newswire 01.30.13 | 09:01 am
- MEI Pharma Announces Closing Of $27.5 Million Private Placement - PR Newswire 12.19.12 | 08:12 am
Partner Headlines for MEIP
- Morning Market Losers - Benzinga 11.26.12 | 09:11 am
